Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
Clinical trial NCT06580873 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06580873
- Sponsor
- Saskatchewan Health Authority - Regina Area
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.